Karl Trygve Kalleberg is a versatile expert in molecular diagnostics and data analytics with extensive experience in both medical and technology sectors. As a co-founder, Chief Scientific Officer, and Chief Technology Officer at Age Labs AS, Kalleberg focuses on developing biomarkers for aging. In addition to advising Sensonomic on translating complex natural capital data, Kalleberg has a robust background in investment and analytics as a partner at Quantility AS. Previous roles include co-founding KolibriFX, serving as an on-call temporary doctor at Oslo universitetssykehus, and holding positions in various hospitals during medical internships. Kalleberg holds degrees in medicine and computer science from the University of Bergen.